Wanbury Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Excellent return on equity (ROE 76.5%)
- Efficient capital deployment (ROCE 36.6%)
- Attractively valued vs sector (P/E 20x vs industry 54.7x)
Concerns
- High premium to book value (P/B 14.6x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
WANBURY · as of Jun 2026
| Category | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 39.79% | 39.79% | 39.77% | 39.76% | 39.76% | 39.63% |
| FII | 0.18% | 0.22% | 1.02% | 0.84% | 1.55% | 1.59% |
| Public | 60.02% | 59.97% | 59.21% | 59.40% | 58.68% | 58.79% |
Latest News
All newsWanbury to hold 38th AGM via video conferencing
*Wanbury to hold 38th AGM via video conferencing.* The company will conduct its **38th Annual General Meeting** through Video Conferencing or Other Audio Visual Means. Details are part of a routine corporate filing with the NSE. No financial or operational updates were provided. 📊 *STOCKS:* $WANBURY | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
Wanbury shares unchanged after newspaper publication filing
*Wanbury shares unchanged after newspaper publication filing.* The company submitted a copy of its newspaper publication as part of regulatory compliance. No financial or operational updates were disclosed. Such filings are routine and do not impact business operations. 📊 *STOCKS:* $WANBURY | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Filing